OPRM1 and cancer: The re-expression of OPRM1 in a cancer pain model may produce antinociception by mediating the effect of endogenous opioids (Viet et al., 2014), and OPRM1 was also one of the genes with rhythmic oscillations in neuropathic pain (Kim et al., 2020).